Literature DB >> 10321980

A mechanism for selective induction of 2'-5' oligoadenylate synthetase, anti-viral state, but not MHC class I genes by interferon-beta in neurons.

P T Massa1, L W Whitney, C Wu, S L Ropka, K W Jarosinski.   

Abstract

Interferon-inducible expression of major histocompatibility class I genes has previously been found to be quantitatively and functionally deficient in neurons compared to other somatic cells or other neural cell types including astrocytes. This deficiency is a key component of neuronal immunoprivilege during viral infections of the CNS. To the contrary, in the present study, induction of functional antiviral state by IFN-beta in neurons compared to astrocytes was found to be highly efficient with respect to both viral replication and protection from cytopathic effects. A candidate antiviral state gene found to be efficiently induced in neurons by IFN-beta was the 2'-5'-oligoadenylate synthetase (OAS) gene. Unlike MHC class I genes, induction of OAS was comparable in neurons and astrocytes indicating differential expression in these neural cell types. Analysis of OAS gene promoter activity indicated that induction of the OAS gene by IFN-beta was dependent on a region containing the interferon stimulated responsive element (ISRE). In contrast, a construct containing the MHC class I-ISRE responsible for induction by IFN-beta in astrocytes was not responsive to IFN-beta in neurons. Therefore, transcription factor binding to the OAS- and MHC-ISREs was analyzed. While the OAS and MHC Class I site bound equal amounts of the transcriptional repressor IRF-2, the OAS-ISRE preferentially interacted with the transcriptional activator ISGF3 in response to IFN-beta. Further, unlike neurons, upregulation of MHC class I genes in astrocytes was related to binding of IRF-1 instead of IRF-2 to the MHC-ISRE. It is proposed that selective activation of anti-viral state genes compared to MHC class I genes by IFN-beta in neurons is mediated by preferential induction and binding of ISGF3 to anti-viral state gene ISREs but not the MHC-ISRE.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10321980     DOI: 10.3109/13550289909021998

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  8 in total

1.  A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Joan Burnside; Henry R Bose
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Innate STAT1-dependent genomic response of neurons to the antiviral cytokine alpha interferon.

Authors:  Jianping Wang; Iain L Campbell
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Extended JAK activation and delayed STAT1 dephosphorylation contribute to the distinct signaling profile of CNS neurons exposed to interferon-gamma.

Authors:  Michael A Podolsky; Andreas C Solomos; Lisa C Durso; Stephanie M Evans; Glenn F Rall; R Wesley Rose
Journal:  J Neuroimmunol       Date:  2012-07-04       Impact factor: 3.478

4.  Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.

Authors:  Paul T Massa; Stacie L Ropka; Sucharita Saha; Karen L Fecenko; Kathryn L Beuler
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

5.  Altered levels of STAT1 and STAT3 influence the neuronal response to interferon gamma.

Authors:  R Wesley Rose; Anna G Vorobyeva; Jason D Skipworth; Emmanuelle Nicolas; Glenn F Rall
Journal:  J Neuroimmunol       Date:  2007-11-19       Impact factor: 3.478

6.  Resistance to IFN-alpha-induced apoptosis is linked to a loss of STAT2.

Authors:  Ana L Romero-Weaver; Hsiang-Wen Wang; Håkan C Steen; Anthony J Scarzello; Veronica L Hall; Faruk Sheikh; Raymond P Donnelly; Ana M Gamero
Journal:  Mol Cancer Res       Date:  2010-01-12       Impact factor: 5.852

Review 7.  Pathogenesis of flavivirus encephalitis.

Authors:  Thomas J Chambers; Michael S Diamond
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

Review 8.  Immune responses to RNA-virus infections of the CNS.

Authors:  Diane E Griffin
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.